This inventor holds 2 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 3 EPO patents. Top assignees: Msd R&d (China) Co., Ltd., Walter and Eliza Hall Institute of Medical Research, Merch Sharpe & Dohme LLC. Active years: 2025.
Company Filing History:


Years Active: 2025
Title: The Innovative Contributions of Brad Sleebs
Introduction
Brad Sleebs is an accomplished inventor based in Bundoora, Australia. He has made significant contributions to the field of medicine, particularly in the development of antimalarial agents. With a total of two patents to his name, Sleebs has focused on innovative methods for treating malaria.
Latest Patents
Sleebs' latest patents include groundbreaking methods of treating malaria through the administration of compounds of Formula (I) or their pharmaceutically acceptable salts. These patents detail the use of these compounds for inhibiting plasmepsin X, plasmepsin IX, or both, which are crucial for treating malaria and related infections. The inventions also encompass methods that may involve the administration of additional antimalarial compounds, showcasing a comprehensive approach to combating this disease.
Career Highlights
Throughout his career, Brad Sleebs has worked with notable organizations, including MSD R&D (China) Co., Ltd. and the Walter and Eliza Hall Institute of Medical Research. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.
Collaborations
Sleebs has had the opportunity to work alongside esteemed colleagues, including John A. McCauley. These collaborations have further enriched his research and development efforts in the fight against malaria.
Conclusion
Brad Sleebs is a notable inventor whose work in antimalarial agents has the potential to make a significant impact on global health. His innovative methods and collaborations highlight the importance of continued research in the medical field.